Sunitinib in Metastatic Renal Cell Carcinoma: Recommendations for Management of Noncardiovascular Toxicities

The multitargeted tyrosine-kinase inhibitor sunitinib has emerged as one of the standards of care for good- and intermediate-risk metastatic renal cell carcinoma. Although generally associated with acceptable toxicity, sunitinib exhibits a novel and distinct toxicity profile that requires monitoring...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kollmannsberger, Christian, Bjarnason, Georg, Burnett, Patrick, Creel, Patricia, Davis, Mellar, Dawson, Nancy, Feldman, Darren, George, Suzanne, Hershman, Jerome, Lechner, Thomas, Potter, Amy, Raymond, Eric, Treister, Nathaniel, Wood, Laura, Wu, Shenhong, Bukowski, Ronald
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2011
Assuntos:
Academia-Pharma Intersect
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228204/
https://ncbi.nlm.nih.gov/pubmed/21490127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0263
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados